FDA Clearance Tracker · P210036
PerClot® Polysaccharide Hemostatic System
Last checked: Nov 20, 2026Latest source record: May 19, 2023 (this decision)Source: openFDAMethods & limitations
Decided
May 19, 2023
Approved
Time to decision
571 days
Received Oct 25, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P210036
- Device name
- PerClot® Polysaccharide Hemostatic System
- Applicant
- Baxter Healthcare Corporation
- Applicant location
- Round Lake, IL
- Received
- Oct 25, 2021
- Decided
- May 19, 2023
- Decision
- Approved
- Supplements
- 8 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Regulation
- 21 CFR 878.4490
- Specialty
- General & Plastic SurgeryWound Care
FDA's approval statement
As written in FDA's record.
Approval for the PerClot® Absorbable Hemostatic Powder. The device is indicated in surgical procedures (except neurological and ophthalmic) as an adjunctive hemostatic device to assist when control of suture line bleeding or capillary, venous and arteriolar bleeding by pressure, ligature, and other conventional procedures is ineffective or impractical.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code LMG. The earliest in FDA's data is N12159, decided Oct 14, 1960.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Baxter Healthcare Corporation
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K251745 · Decided Dec 16, 2025 · 193 days after receipt
Device type: Blood Pressure Cuff (DXQ) · Cardiology
K251636 · Decided Jul 28, 2025 · 60 days after receipt
Device type: Pump, Infusion (FRN) · Hospital Medicine & Nursing
K251640 · Decided Jul 28, 2025 · 60 days after receipt
Device type: Pump, Infusion (FRN) · Hospital Medicine & Nursing
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.